CORD-19:c654596857bce9cdd64ffc51842048643107348c / 367572-367695 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3149","span":{"begin":0,"end":123},"obj":"Sentence"},{"id":"T8264","span":{"begin":0,"end":123},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Interestingly, patients with genotype C who became HBeAg negative by interferon treatment had high ALT abnormality (58.8%)."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T474","span":{"begin":0,"end":123},"obj":"Epistemic_statement"}],"text":"Interestingly, patients with genotype C who became HBeAg negative by interferon treatment had high ALT abnormality (58.8%)."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T149","span":{"begin":0,"end":123},"obj":"Sentence"}],"text":"Interestingly, patients with genotype C who became HBeAg negative by interferon treatment had high ALT abnormality (58.8%)."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1802","span":{"begin":38,"end":39},"obj":"Disease"},{"id":"T1803","span":{"begin":99,"end":102},"obj":"Disease"}],"attributes":[{"id":"A1802","pred":"mondo_id","subj":"T1802","obj":"http://purl.obolibrary.org/obo/MONDO_0005688"},{"id":"A1803","pred":"mondo_id","subj":"T1803","obj":"http://purl.obolibrary.org/obo/MONDO_0005103"},{"id":"A1804","pred":"mondo_id","subj":"T1803","obj":"http://purl.obolibrary.org/obo/MONDO_0006097"}],"text":"Interestingly, patients with genotype C who became HBeAg negative by interferon treatment had high ALT abnormality (58.8%)."}